In contrast, reducing TUG1 expression in ICC cells resulted in a significant decrease in glutamine consumption, α-ketoglutarate production, and ATP levels, while inhibition of miR-145 reversed these effects. Here, TUG1 is linked to intrahepatic cholangiocarcinoma.